Phase 1 PK Study to Evaluate the PK of CIN-107 in Subjects With Hepatic Impairment
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Eric Lawitz, MD
American Research Corporation at the Texas Liver Institute
Principal InvestigatorKOL profile → - Kimberly Cruz, MD
Advanced Pharma CR
Principal Investigator - Thomas Marbury, MD
Orlando Clinical Research Center
Principal Investigator - William B Smith,, MD
Alliance for Multispecialty Research
Principal Investigator - Zeid Kayali, MD
Inland Empire Clinical Trials
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Inland Empire Clinical Trials
Rialto, California, United States
- Advanced Pharma Cr
Miami, Florida, United States
- Orlando Clinical Research Center
Orlando, Florida, United States
- Alliance for Multispecialty Research
Knoxville, Tennessee, United States
- American Research Corporation at the Texas Liver Institute
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Aug 2021
- Primary completion
- 15 Apr 2022
- Completion
- 15 Apr 2022
- Last update posted
- 14 Aug 2023
- Registered enrollment
- 20
- Registry id
- NCT05961397
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.